(1)
Fiorentino, F.; Canali, B.; Morelli, P.; Demma, F. Brentuximab Vedotin in Combination With Doxorubicin, Vinblastine and Dacarbazine for First-Line Treatment of Stage IV HL: Cost Impact on Subsequent Lines in Italy. AboutOpen 2023, 10, 6-12.